NL-OMON34735尚未招募不适用
The effects of antithymocyte globulin (ATG) on the endothelial glycocalyx in kidney transplant recipients - ATG/endothelial glycocalyx/kidney transplantation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Female or male, age between 18 and 70 years
- •Kidney transplant recipient
- •ATG therapy because of an allograft rejection
- •Given written informed consent
排除标准
- •Diabetes Mellitus
研究者
相似试验
已完成
不适用
Anti-thymocyte Globulin-induced Immune SenescenceDisorder Related to Renal TransplantationNCT02857907Centre Hospitalier Universitaire de Besancon97
已完成
不适用
A multicenter pilot study of antithymocyte globulin in patients undergoing allogeneic peripheral blood stem cell transplantatiohematological malignanciesJPRN-UMIN000017170orth Japan Hematology Study Group (NJHSG)6
已完成
不适用
T cell homeostasis after ATG induced lymphocytopenia in renal transplant patients; studied through in vivo 2H2O labelinglow white blood cellslymphocytopenia100479541002766510018188NL-OMON35541Academisch Medisch Centrum9
已完成
不适用
Safety and efficacy of thymoglobulin (ATG) for cord blood transplantation for hematologic malignanciesHematologic malignancies with an indication for allogeneic hematopoietic stem cell transplantation (allo- HSCT) Acute myeloid leukemia Myelodysplastic syndrome Chronic myeloid leukemia Malignant lymphoma Acute lymphoblastic leukemiaJPRN-UMIN000004206Hematology, Osaka City University, Graduate School of Meicine7
招募中
3 期
Safety and efficacy of Anti-Thymocyte Globulin (Zist Kowsar Pharmaceutical Company) in comparison with Anti-Thymocyte Globulin (Genzyme) for immunosuppressive induction therapy in adults with renal transplantatioIRCT20100127003200N6Kowsar Biotechnology company129